Create account to read this article for free
Get free access to a limited number of articles.
The pharmaceutical industry's call to the EU: Act!
A large number of global pharmaceutical giants are threatening to move research and manufacturing out of the EU unless Ursula von der Leyen acts quickly to counter US trade policy. At the same time, Swedish industry associations are pressing...
Notes
Alligator Bioscience receives FDA approval for phase III mitazalimab dose
Lena Åredal appointed new CEO of SyntheticMR
BioArctic advances phase IIa study with exidavnemab
Novo Nordisk advances amycretin to Phase III
BioNTech acquires CureVac for $1,25 billion
NEWSLETTER
NEWS
AstraZeneca in billion-dollar deal in AI
Kancera rises on positive results from the KANDOVA study
New success strengthens Alzinova's licensing opportunities for ALZ-101
Upcoming events!
Investing in Life Science
We cover early-stage, growth-stage and late-stage investments. From business angels and seed investors driving medical breakthroughs, to investments empowering promising...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
Bispecific and Chinese the new black in cancer
The venture capital cycle is complete – we are back where we started
